XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Significant Accounting Policies  
Schedule of disaggregated revenue

Three Months Ended June 30, 

Diagnostics

Therapeutic
Devices

Consolidated

  

2024

  

2023

  

2024

  

2023

  

2024

  

2023

Capital

$

125

$

67

$

1,605

$

1,893

$

1,730

$

1,960

Consumables

294

182

4,067

3,849

4,361

4,031

Other

-

-

40

29

40

29

Total revenue

$

419

$

249

$

5,712

$

5,771

$

6,131

$

6,020

Six Months Ended June 30, 

Diagnostics

Therapeutic
Devices

Consolidated

  

2024

  

2023

  

2024

  

2023

  

2024

  

2023

Capital

$

575

$

284

$

3,379

$

3,386

$

3,954

$

3,670

Consumables

588

364

7,783

7,416

8,371

7,780

Other

-

-

68

52

68

52

Total revenue

$

1,163

$

648

$

11,230

$

10,854

$

12,393

$

11,502